The plateau in liver disease mortality in Germany: contrasting trends by age, region and ICD-10 code, 2000-2024

Background: Cirrhosis is often diagnosed only at decompensation, making identification of high-risk groups important for prevention and early detection. Chronic liver disease mortality has fallen in southern Europe and France since 2010, but not in Germany. Whether the German plateau reflects birth-cohort alcohol exposure, metabolic liver disease or certification practice is unknown. Methods: Deaths by ICD-10 code, sex and age group were extracted from the WHO Mortality Database for 16 European countries (2000-2022), with Eurostat rates (2011-2023), German state-level mortality (1998-2024) and hospital diagnoses (2000-2023). Registry and Global Burden of Disease Study (GBD) 2023 estimates were summarised for ages 45-64, 65-74 and 75 years and over, with registry rates standardised to the European Standard Population 2013. Findings: Germany's age-standardised chronic liver disease mortality was 16.6 per 100 000 in 2011 and 16.0 in 2023, against declines of 21-37% in France, Italy and Spain. Between 2010 and 2022, alcoholic liver disease mortality at ages 45-64 fell by 17% in men and 25% in women, whereas fibrosis and cirrhosis (K74) mortality at ages 65-74 rose by 27% and 28%, with larger K70-K77 mortality increases in eastern than western Germany. Hospitalisation rates showed similar age-specific patterns, while in-hospital case fatality declined. Fewer than 0.5% of liver deaths were certified as fatty liver. GBD 2023 showed a similar age-specific increase but attributed rising mortality to all five modelled aetiologies. Interpretation: The German plateau reflects continued decline below age 65 and rising mortality at ages 65-74, compatible with cohorts born 1945-59 reaching this age band, particularly in eastern Germany. Consumption records and surveys indicate differing regional patterns of alcohol exposure. Much of the cirrhosis in these cohorts is certified without aetiology, and GBD's aetiological estimates cannot be verified in registration data. Funding: None.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.26368157
Primary Topic
Alcohol Consumption and Health Effects
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The plateau in liver disease mortality in Germany: contrasting trends by age, region and ICD-10 code, 2000-2024

Lisa C. Adams, Keno K. Bressem, Nicolas S. Lenhart, Sebastian Ziegelmayer et al.
medRxiv
Alcohol Consumption and Health Effects
preprint

The plateau in liver disease mortality in Germany: contrasting trends by age, region and ICD-10 code, 2000-2024

Lisa C. Adams, Keno K. Bressem, Nicolas S. Lenhart, Sebastian Ziegelmayer, Markus M. Graf, Marcus R. Makowski, Miriam Kumpf, Era Stambollxhiu, Eva Wende
preprint en

Abstract

Background: Cirrhosis is often diagnosed only at decompensation, making identification of high-risk groups important for prevention and early detection. Chronic liver disease mortality has fallen in southern Europe and France since 2010, but not in Germany. Whether the German plateau reflects birth-cohort alcohol exposure, metabolic liver disease or certification practice is unknown. Methods: Deaths by ICD-10 code, sex and age group were extracted from the WHO Mortality Database for 16 European countries (2000-2022), with Eurostat rates (2011-2023), German state-level mortality (1998-2024) and hospital diagnoses (2000-2023). Registry and Global Burden of Disease Study (GBD) 2023 estimates were summarised for ages 45-64, 65-74 and 75 years and over, with registry rates standardised to the European Standard Population 2013. Findings: Germany's age-standardised chronic liver disease mortality was 16.6 per 100 000 in 2011 and 16.0 in 2023, against declines of 21-37% in France, Italy and Spain. Between 2010 and 2022, alcoholic liver disease mortality at ages 45-64 fell by 17% in men and 25% in women, whereas fibrosis and cirrhosis (K74) mortality at ages 65-74 rose by 27% and 28%, with larger K70-K77 mortality increases in eastern than western Germany. Hospitalisation rates showed similar age-specific patterns, while in-hospital case fatality declined. Fewer than 0.5% of liver deaths were certified as fatty liver. GBD 2023 showed a similar age-specific increase but attributed rising mortality to all five modelled aetiologies. Interpretation: The German plateau reflects continued decline below age 65 and rising mortality at ages 65-74, compatible with cohorts born 1945-59 reaching this age band, particularly in eastern Germany. Consumption records and surveys indicate differing regional patterns of alcohol exposure. Much of the cirrhosis in these cohorts is certified without aetiology, and GBD's aetiological estimates cannot be verified in registration data. Funding: None.

medRxiv
Technical University of Munich (DE)
Good health and well-being
Alcohol Consumption and Health Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon